| Aug 5 |
BioCryst Pharmaceuticals (BCRX) Q2 2024 Earnings Call Transcript
|
| Aug 5 |
BioCryst Pharmaceuticals, Inc. 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 5 |
BioCryst Pharmaceuticals, Inc. (BCRX) Q2 2024 Earnings Call Transcript
|
| Aug 5 |
Can BioCryst (BCRX) Climb 99.43% to Reach the Level Wall Street Analysts Expect?
|
| Aug 5 |
BioCryst Pharmaceuticals (BCRX) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 5 |
Earnings summary: BioCryst Pharmaceuticals beats Q2 estimates; raises FY24 global net ORLADEYO revenue outlook
|
| Aug 5 |
BioCryst: Q2 Earnings Snapshot
|
| Aug 5 |
BioCryst Pharmaceuticals Non-GAAP EPS of -$0.06 beats by $0.10, revenue of $109.33M beats by $11.01M
|
| Aug 5 |
BioCryst Reports Second Quarter 2024 Financial Results and Provides Business Update
|
| Aug 2 |
BioCryst Pharmaceuticals Q2 2024 Earnings Preview
|
